| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.18 | 0.002 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.17 | 0.003 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.004 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.14 | 0.004 |